A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada

Withdrawn before enrolling

Conditions studied: Uterine Fibroids

In brief

This is a non-interventional, cross-sectional survey study to evaluate the effectiveness of the Additional Risk Minimization Measures for Fibristal among Healthcare Professionals (HCPs).

Key facts

Study ID

NCT04567589

Run by

Allergan

People needed

0

Starts

2020-09-30

Expected to finish

2021-02-28

Last updated by the study team

2020-10-22

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HCPs have prescribed Fibristal for the indication of uterine fibroids within the past 6 months.
• HCPs have provided permission to share their responses in aggregate to Health Canada.

You may not qualify if…

• HCPs who participated in the cognitive pre-testing of the survey questionnaire to be used for the study.
• HCPs who have been direct employees of Allergan, ICON, Health Canada, or Professional Targeted Marketing (PTM) within the past 5 years.

Where it is running

• Clinical Trials Registry Team — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.